BiVictriX Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BiVictriX Therapeutics generated cash of -$1,938,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,935,000 last year. Net change in cash is therefore -$8,000.
Cash Flow
| 2018 | -484K | 0 | 553K |
|---|---|---|---|
| 2019 | -357K | 0 | 275K |
| 2020 | -166K | -63K | 962K |
| 2021 | -1.78M | -46K | 7.03M |
| 2022 | -2.39M | -379K | 0 |
| 2023 | -1.93M | -5K | 1.93M |
BVX.L Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 3.28M | 6.06M | 862K | 129K | 211K | 142K |
Operating activities | ||||||
Net income | -2.54M | -2.97M | -2.53M | -490K | -526K | -480K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 165K | 151K | 46K | 1K | 0 | 0 |
Stock-based compensation expense | 74K | 127K | 224K | 4K | 4K | 0 |
| Deferred income tax benefit | 74K | 127K | 224K | 4K | 4K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 80K | 63K | -227K | -41K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -1.93M | -2.39M | -1.78M | -166K | -357K | -484K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5K | -389K | -46K | -63K | 0 | 0 |
Acquisitions Net | 0 | 10K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -5K | -379K | -46K | -63K | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 2.13M | 0 | 7.5M | 179K | 287K | 565K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -800K | 0 | 0 |
Cash used in financing activities | 1.93M | 0 | 7.03M | 962K | 275K | 553K |
Net Change In Cash | -8K | -2.77M | 5.20M | 733K | -82K | 69K |
Cash at end of period | 3.27M | 3.28M | 6.06M | 862K | 129K | 211K |
| Data source | Data source | Data source | Data source | Data source | Data source |